Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: a comparative study

AS Mohamed, HM Ahmad, ASA Abdul-Raheem… - Research in Social and …, 2022 - Elsevier
Background Many thrombotic complications are linked to coronavirus disease 2019 (COVID-
19). Antithrombotic treatments are important for prophylaxis against these thrombotic events …
被引用次数：5 相关文章

Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative study

AS Mohamed, HM Ahmad… - Research in social …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Many thrombotic complications are linked to coronavirus disease 2019 (COVID-
19). Antithrombotic treatments are important for prophylaxis against these thrombotic events …

Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative study.

AS Mohamed, HM Ahmad… - Research in Social & …, 2022 - europepmc.org
Background Many thrombotic complications are linked to coronavirus disease 2019 (COVID-
19). Antithrombotic treatments are important for prophylaxis against these thrombotic events …
[HTML] nih.gov

[HTML][HTML] Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative study

AS Mohamed, HM Ahmad… - Research in Social & …, 2022 - ncbi.nlm.nih.gov
Background Many thrombotic complications are linked to coronavirus disease 2019 (COVID-
19). Antithrombotic treatments are important for prophylaxis against these thrombotic events …